Wall Street bankers shift focus to busy 2026 after cashing in on big deals

U.S. investment banks reported stronger fourth-quarter results driven by a surge in dealmaking and trading: Goldman Sachs' investment banking fees rose 25%, Morgan Stanley's investment-banking revenue jumped 47%, Citigroup logged record M&A advisory revenue, while Bank of America saw only a 1% rise and JPMorgan experienced weaker investment-banking revenues despite leading industry fees. Global investment-banking revenues topped $100 billion in 2025, trading profits were bolstered by market volatility (Goldman reported record equities revenue), and banks say a robust 2026 pipeline—spurred by expected IPOs (including OpenAI, SpaceX, Cerebras), sponsor exits and lower cost of capital after 2025 Fed cuts—should sustain fee and trading momentum.

Analysis

Market structure: Banks with large capital-markets and trading franchises (GS, MS, WFC, C) are clear near-term winners as IPO/M&A pipelines and higher intraday volatility lift fee and trading revenue; expect 10–20% QoQ uplift in IB/trading contribution for top-tier dealers in active quarters versus regional lenders that lack origination scale. Supply/demand for underwriting and block liquidity will tighten around marquee listings (OpenAI, SpaceX, Cerebras), increasing fee pricing power and market share for banks that secure mandates; conversely, issuers may face temporary windows of overheated demand followed by mean reversion.

Risk assessment: Key tail risks include regulatory intervention on mega-deals (FTC/DOJ action within 60–120 days), sudden Fed-driven liquidity shocks if credit tightens, and a failed IPO wave that re-prices PE exit prospects; probability moderate but impact high (deal revenues could drop >40% in a stressed quarter). Short-term (days–weeks) earnings surprises and deal announcements will move stocks; medium-term (3–12 months) depends on deal closings and rate trajectory; long-term (12–36 months) hinges on sustained fee margin recovery and PE exit volumes.

Trade implications: Direct plays favor overweight GS and MS (fee + trading exposure) and WFC for advisory share gains; pair trades: long GS/MS vs short JPM/BAC to capture execution and momentum differences. Options strategies: buy 3–6 month call spreads on GS/MS ahead of quarterly calls and purchase 1–3 month straddles on event-driven names (WBD, EA) around deal milestones to monetize volatility spikes.

Contrarian angles: Consensus underprices regulatory and credit-cycle sequencing risk — a string of large LBOs (EA-style) could reverse if debt markets tighten, making leveraged-buyout beneficiaries (private-credit, junk-bond ETFs) vulnerable. Historical parallel: 2006–07 deal booms saw rapid fee upside then sharp reversals; avoid crowding into cyclical fee narratives without liquidity and covenant checks.

Key Decisions for Investors

• Establish a 2–3% long position in Goldman Sachs (GS) within 1–2 weeks, target +15% upside over 6 months (catalyst: higher IB fees and record equities trading), set a hard stop-loss at -8% and trim 50% at +10%.
• Initiate a market-neutral pair: long Morgan Stanley (MS) and short JPMorgan (JPM) equal notional (1:1) for a 3–6 month trade to capture relative IB/trading momentum; target MS outperformance of 8% vs JPM, stop the pair if spread moves >6% adverse within 30 days.
• Buy a 3–6 month call spread on MS (buy ATM, sell +15% strike) sized to 1% of portfolio to limit premium outlay while participating in upside from M&A/IPOs; roll or exit if announced IPO pipeline misses consensus over two sequential reporting cycles.
• Short Warner Bros Discovery (WBD) or buy 1–3 month ATM put spreads (limit exposure to 0.5–1% portfolio) ahead of anticipated bidding resolution; target 20–30% downside if deal process stalls or regulatory hurdles appear in next 60–90 days, stop at -10% loss.
• Reduce passive exposure to large universal banks with weak IB execution (reduce BAC/JPM weight by 1–2% each) and reallocate to GS/MS/WFC; reassess after 2 earnings cycles or after DOJ/FTC rulings on major media/M&A within 90–120 days.